Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04350125 · ClinicalTrials.gov registry record · Phase 1
PRP for the Treatment of Erectile Dysfunction (ED)
A Phase 1 study of Erectile Dysfunction, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
- 1
- Study location
NCT04350125 is a Phase 1 study of Erectile Dysfunction that has completed, run by Mayo Clinic. The registered enrollment target is 4 participants, below the 232-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04350125, a Phase 1 study of Erectile Dysfunction, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are trying to determine the safety and efficacy of Platelet Rich Plasma (PRP) in the treatment of Erectile Dysfunction (ED).
Conditions Studied
Interventions
- BIOLOGICAL Autologous Platelet Rich Plasma
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2022-03-04 |
| Est. Completion | 2023-10-23 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04350125
The ClinicalTrials.gov registry entry for NCT04350125 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 232-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (98% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Erectile Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Autologous Platelet Rich Plasma is the first listed.
NCT04350125 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04350125 about?
NCT04350125 is a clinical study titled "PRP for the Treatment of Erectile Dysfunction (ED)". Researchers are trying to determine the safety and efficacy of Platelet Rich Plasma (PRP) in the treatment of Erectile Dysfunction (ED).
What is the current status of trial NCT04350125?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2022-03-04. Estimated completion is 2023-10-23.
What conditions does trial NCT04350125 study?
This clinical trial studies the following conditions: Erectile Dysfunction.
What interventions are being tested in trial NCT04350125?
The interventions under investigation include: Autologous Platelet Rich Plasma (BIOLOGICAL).
Who is sponsoring clinical trial NCT04350125?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04350125 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Erectile Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects
RECRUITING · Phase 1
-
Drug Interaction Study of Avanafil and Enalapril or Amlodipine
COMPLETED · Phase 1
-
Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease
RECRUITING · NA
-
Double-S: a Wearable Device for Erectile Dysfunction
RECRUITING · NA
-
Safety and Efficacy of the VERTICA® RF Device for the Treatment of ED
RECRUITING · NA
-
The Impact of Dietary Pattern on Erectile Function
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.